Deciphex

company

About

Deciphex uses digital pathology and AI to address the pathology productivity gap

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$11.50M
Industries
Artificial Intelligence,Biotechnology,Health Diagnostics,Software
Founded date
Jan 1, 2017
Number Of Employee
51 - 100
Operating Status
Active

Deciphex is an Irish-based software company focused on developing digital pathology-based solutions for clinical and research pathology. Our ambition is to deliver solutions that provide tangible productivity benefits to pathologists, eliminating low-level tasks so they can focus on the critical content. We believe that digital pathology combined with artificial intelligence will help make pathologists work more efficiently in the future, offering a solution to the pending challenges in supply/demand in pathology services. Deciphex plans to be at the forefront of this revolution with cleverly positioned solutions that deliver on the biggest problems facing pathology today.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$17.70M €2.30M
Deciphex has raised a total of $17.70M €2.30M in funding over 2 rounds. Their latest funding was raised on May 19, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 19, 2022 Series B $11.50M 2 Detail
Jul 16, 2020 Series A $6.20M 1 Detail
Apr 15, 2019 Series Unknown €2.30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Deciphex is funded by 2 investors. NextSteps Capital and HBAN Medtech Syndicate are the most recent investors.
Investor Name Lead Investor Funding Round
NextSteps Capital Series B
HBAN Medtech Syndicate Series B